Haruko Obokata

Haruko Obokata
Name	Haruko Obokata
Birth date	1983
Birth place	Matsudo, Chiba, Japan
Nationality	Japanese
Fields	Cell biology, Stem cell research
Alma mater	Waseda University, University of Tokyo
Known for	STAP cell controversy

Haruko Obokata is a Japanese stem cell biologist who became internationally known following claims about a novel method for creating pluripotent cells and the subsequent scientific controversy. Her work intersected with institutions and figures across Japan, United States, and United Kingdom research communities, drawing attention from major outlets and scientific bodies. The episode implicated journals, universities, funding agencies, and research ethics organizations, and spurred discussion in fields ranging from developmental biology to bioethics.

Early life and education

Obokata was born in Matsudo, Chiba, and received her early education in Chiba Prefecture before attending Waseda University for undergraduate studies, where she studied subjects related to life sciences. She pursued graduate work at the University of Tokyo and later conducted research at institutions including the RIKEN research institute and the Whitehead Institute for Biomedical Research, collaborating with researchers connected to laboratories at Harvard University, Massachusetts Institute of Technology, and other centers. During her training she encountered mentors and colleagues from laboratories linked to figures such as Shinya Yamanaka, Masahiro Morita, and researchers affiliated with the National Institutes of Health, Wellcome Trust, and other funding organizations.

Research career

Obokata's early publications and conference presentations touched on topics in cell biology and regenerative medicine that intersected with work by scientists such as Yoshiki Sasai, Charles Vacanti, Hanna M., and groups at Kyoto University, Osaka University, and Keio University. Her research trajectory included laboratory techniques and model systems used by teams in developmental and stem cell biology across laboratories directed by investigators like Walt Whitman, George Daley, Rudolf Jaenisch, and researchers associated with MIT and Stanford University. She collaborated with postdoctoral researchers and technicians trained under principal investigators from institutions such as University College London, Cold Spring Harbor Laboratory, and national research councils in Japan and abroad.

Her reported method claimed a simple stimulus could induce somatic cells to acquire pluripotency, a concept related to earlier discoveries by Nobel laureates and groups including John Gurdon and Shinya Yamanaka, and building upon techniques developed in laboratories at Cambridge University, University of California, San Francisco, and other centers that study reprogramming, nuclear transfer, and stem cell derivation.

STAP cell controversy

In 2014 Obokata co-authored papers published in leading journals that described "stimulus-triggered acquisition of pluripotency" (STAP) cells, a claim that drew immediate attention from the scientific community. The articles were scrutinized by editors at journals such as Nature and researchers at institutions including RIKEN, Kyoto University, University of Tokyo, Harvard Medical School, and Massachusetts General Hospital. Critics compared figures and data to prior work from labs at Riken Center for Developmental Biology, Salk Institute, European Molecular Biology Laboratory, NIH, and research groups led by investigators such as Rudolf Jaenisch and George Daley.

Allegations emerged concerning image manipulation and data irregularities, prompting inquiries by committees including panels constituted by RIKEN, external reviewers from organizations like Royal Society-associated groups, and ethicists from institutions such as University of Oxford and Stanford University. Media coverage in outlets such as The New York Times, The Guardian, BBC, NHK, and Asahi Shimbun amplified debates that also involved legal advisers, institutional press offices, and national science ministries.

Investigation and retraction

Following investigations, RIKEN and journal editors assembled review committees drawing expertise from scientists affiliated with Cambridge University, Imperial College London, Max Planck Society, and Johns Hopkins University. Committees examined primary data, laboratory notebooks, and collaborative correspondence involving researchers at RIKEN, Cytogenetics facilities, and partner laboratories. Findings cited image duplication and inconsistencies similar to concerns raised in cases involving other retracted studies from diverse institutions including University of Miyazaki and international labs.

As a result, the papers were retracted by Nature, and RIKEN issued reports critiquing experimental record-keeping and supervisory oversight. The episode prompted response from funding agencies such as the Japan Society for the Promotion of Science, professional societies in cell biology and developmental biology, and spurred policy reviews at universities including University of Tokyo, Kyoto University, and research institutes like RIKEN and Keio University.

Later career and public life

After the controversy, Obokata stepped back from frontline academic positions and engaged with activities that included public communication, writing, and interactions with media organizations such as NHK, Asahi Shimbun, and international broadcasters. Discussions about research integrity led to reforms at institutions and influenced training programs at organizations like RIKEN, Waseda University, and governmental science councils. The case became a reference point in debates at conferences hosted by groups such as EMBO, Cold Spring Harbor Laboratory, Society for Developmental Biology, and workshops organized by national academies including the Japan Academy and international bodies.

Obokata's situation remains cited in analyses by ethicists, science historians, and policy makers from institutions like University of Oxford, Harvard University, Stanford University, and University College London when examining reproducibility, peer review, and mentorship in high-profile biomedical research.

Category:Japanese biologists Category:Stem cell researchers